The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
Shares of Medtronic (NYSE:MDT) reached a session low on Tuesday after the U.S. Food and Drug Administration (FDA) announced a ...
Medtronic (NYSE:MDT) shares snapped seven straight days of losses as the stock closed 0.85% higher, at $88.98 on Thursday. ...
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
FDA Classifies Recall of Medtronic Embolization Devices as 'Most Serious' (Reuters) -The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as ...
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...
The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.
The US Food and Drug Administration (FDA) has tagged Medtronic’s recall of certain Pipeline Vantage embolisation devices as Class I following reports of four patient deaths. A Class I recall is ...
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
The FDA announced that Medtronic initiated a device recall and correction for embolization devices. The FDA has identified ...
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results